European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

MediGate GmbH, Hamburg, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

MediGate GmbH

Identification

Ut
District Court of Hamburg HRB 89986
EUID
DEK1101R.HRB89986

Address

Martinistr. 52, 20249 Hamburg, Germany

Corporate purpose

A) the promotion of basic university clinical research in university medicine through appropriate commitment in the field of clinical studies, knowledge exploitation as well as in the acquisition and management of third-party funds, b) the structural improvement of networking with industry and the integration of knowledge transfer and resource transfer. This includes in particular: . The acquisition, support and administrative implementation of clinical trials … Show more

Financial performance

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Network

Loading network

Legal Structure

tax haven banner

Financials

Publications

21 Jan 2026 via UKE Business Services GmbH & Co. KG also 10/01/2025, 21/02/2024, 05/01/2023, 20/12/2021, 10/12/2020, 06/12/2019, 12/12/2018, 15/12/2017, 12/12/2016, 08/12/2015, 09/12/2014, 18/12/2013
Shareholder: UKE Business Services GmbH & Co. KG
20 Jan 2026
Annual report for the year ending 31/12/2024 · Balance sheet for 31/12/2024 · Earnings statement for 31/12/2024 · Shareholding: MediGate GmbH
4 Feb 2025 via Universitätsklinikum Hamburg-Eppendorf (UKE) also 16/12/2024, 03/01/2023, 09/12/2022
Shareholder: Universitätsklinikum Hamburg-Eppendorf (UKE)
15 Jan 2025
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023 · Shareholding: MediGate GmbH
1 Sept 2024 in Fts
EU funding (€39,477): 101161236 - Althea - Tackling Mental Health Cancer Patients and Their Families: Digital Solutions for Better Care
26 Feb 2024 via Universitätsklinikum Hamburg-Eppendorf Körperschaft des also 15/01/2024
Shareholder: Universitätsklinikum Hamburg-Eppendorf Körperschaft des
19 Dec 2023
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022 · Shareholding: MediGate GmbH
Year 2023 in Fts
4 EU fundings (total €3,449,632): 101155946 - ERN Paedcan-Y7-Y10 - European Reference Network on Paediatric Cancer …
10 Feb 2023
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021
1 Nov 2022 in Fts
EU funding (€372,701): 101080009 - CAN.Heal - Building the EU Cancer and Public Health Genomics Platform
1 Nov 2022 in Fts
EU funding (€50,053): 101079887 - Eurotractor - European Transplant and Cellular Therapy Online Registry
14 Jul 2022
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020
1 Mar 2022 as UNIVERSITATSKLINIKUM HAMBURG-EPPENDORF
EU funding (€1,064,923): 101085066 - ERN Rare-Liver - Continuation of ERN Rare-Liver Activities
20 Jan 2022 via Universitätsklinikum Hamburg-Eppendorf (UKE) also 03/01/2022, 02/02/2021, 16/12/2020, 04/02/2020, 23/12/2019, 15/01/2019, 19/12/2018, 18/12/2017, 18/12/2017
Shareholder: Universitätsklinikum Hamburg-Eppendorf Körperschaft des Öffentlichen Rechts
20 Jan 2021
No longer Managing Director: Ralf Krappa
1 Jan 2021 in Fts
EU funding (€259,493): 957715 - Impresa - Implementing Methamphetamine Prevention Strategies Into Action
30 Dec 2020
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
1 May 2020 as UNIVERSITATSKLINIKUM HAMBURG-EPPENDORF
EU funding (€187,105): 945761 - R-Liver - (R-Liver) Registry for Rare Liver Diseases
15 Jan 2020
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018
1 Sept 2019 in Fts
EU funding (€137,560): 2018-EU-IA-0187 Inea/CEF/ICT/A2018/1817070 ERN Rare Liver Training and Support
20 May 2019
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Shareholding: MediGate GmbH
26 Apr 2019
Managing Director: Silke Schrum
1 Mar 2019 as UNIVERSITATSKLINIKUM HAMBURG-EPPENDORF
EU funding (€496,275): 869229 - ERN Rare Liver - ERN Rare Liver: the European Reference Network in Rare Liver Disease
1 May 2018 in Fts
EU funding (€269,059): 801493 - Healthy Gateways - Preparedness and Action AT Points of Entry
2 Feb 2018
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016
13 Dec 2017
Managing Director: Ralf Krappa
16 Nov 2017
Original document: “Gesellschaftsvertrag / Satzung / Statut“
1 Sept 2017 in Fts
EU funding (€8,580.82): 738145 - Transpose - Transfusion and Transplantation: Protection and Selection of Donors
Year 2017 in Dpmam
4 trademark filings
1 May 2017 in Fts
EU funding: Development and Promotion of Recommendations for a Healthy and Safe Working Environment through the Design of Ergonomic Workplaces and Work Processes in the Hairdressing Sector (Ergohair)
1 Apr 2017 in Fts
EU funding (€101,419): 738055 - Localize IT - Local Strategies to Reduce Underage and Heavy Episodic Drinking
30 Jan 2017 via Universitätsklinikum Hamburg-Eppendorf (UKE) also 25/01/2017, 04/02/2016, 26/03/2015, 06/03/2014, 03/12/2012, 03/12/2012
Shareholder: Universitätsklinikum Hamburg-Eppendorf Körperschaft Öffentlichen Rechts
16 Dec 2016
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015
1 Nov 2016 in Fts
EU funding: Civil Society Involvement in Drug Policy
5 Feb 2016 via Universitätsklinikum Hamburg-Eppendorf (UKE)
Annual report · Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014 · Shareholdings (21 companies)
4 Jan 2016
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014
1 Oct 2015 in Fts
EU funding (€204,710): 677085 - HA-React - Joint Action on HIV and CO-Infection Prevention and Harm Reduction
20 Mar 2015 via Universitätsklinikum Hamburg-Eppendorf (UKE)
Annual report · Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013 · Shareholdings (22 companies)
12 Dec 2014
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013
1 Apr 2014 in Fts
EU funding: HCV Treatment AS Prevention in Europe: Model Projections of Impact and Strengthening Evidence Base on Intervention Coverage and Effect and HCV Morbidity
3 Mar 2014
German Patent and Trademark Office (Trademark Records)
3 Mar 2014
German Patent and Trademark Office (Trademark Records)
6 Jan 2014 via Universitätsklinikum Hamburg-Eppendorf (UKE)
Annual report · Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012 · Shareholdings (21 companies)
19 Dec 2013
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012
1 Oct 2013 in Fts
EU funding (€161,655): Gannet53
1 Jan 2013 in Fts
EU funding (€792,600): A Systems Biology Approach to Resolve the Molecular Pathology of two Hallmarks of Patients with Metabolic Syndrome and its co-Morbidities; Hypertriglyceridemia and low …
12 Dec 2012
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011
20 Jan 2012
Profit Transfer: UKE Business Services GmbH & Co. KG
12 Jan 2012
No longer Profit Transfer: Der mit dem Universitätsklinikum Hamburg-Eppendorf KöR
11 Jan 2012
Original document: “Liste der Gesellschafter“
2 Jan 2012
Original document: “Liste der Gesellschafter“
9 Dec 2011
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
1 Jul 2011 via Analytical Services North GmbH
Merger: Analytical Services North GmbH
1 Jul 2011
Merger: Analytical Services North GmbH · Address
22 Jun 2011
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
22 Jun 2011
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
22 Jun 2011
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
17 Jan 2011
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009
6 Jan 2011 via Universitätsklinikum Hamburg-Eppendorf (UKE) also 16/12/2010, 28/07/2009, 20/03/2009
Shareholder: Universitätsklinikum Hamburg-Eppendorf (UKE) Körperschaft des öffentlichen Rechts
4 Feb 2010
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008
17 Feb 2009
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007
6 Mar 2008
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006
6 Feb 2007
Word figurative mark: “NORTH CTC“
15 Dec 2006
Profit Transfer: Mit dem Universitätsklinikum Hamburg-Eppendorf KöR
6 Oct 2005
Managing Director: Ralf Krappa · No longer Managing Director (1)
8 Mar 2005
Managing Director (2)
9 Mar 2004
Reg­is­tra­tion · Managing Director (1) · Capital: €25,000 · Seat: Hamburg · Legal form: GmbH · Name: MediGate GmbH · Proxy policy · Corporate Purpose
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.